[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [HEALTH]

2 clusters · 10 sources · 9 days · First seen · Last updated

Global safety concerns regarding GLP-1 weight loss drugs

Overview

Health authorities are monitoring a surge in reported adverse reactions and deaths linked to GLP-1 receptor agonists used for weight loss and diabetes, including semaglutide, tirzepatide, and liraglutide.

Initial reports from the UK Medicines and Healthcare products Regulatory Agency (MHRA) identified 216 suspected deaths and over 158,000 suspected adverse reactions. Tirzepatide was noted for having the highest number of reports, including 120 deaths. The MHRA clarified that these reports do not establish a causal link but serve as a basis for further investigation.

As monitoring expanded globally, additional data emerged from Australia, where the TGA recorded 62 deaths, and Croatia, where HALMED noted 333 suspected side effect reports. In the United States, 216 lawsuits have been consolidated into a federal proceeding concerning alleged vision damage. Specifically, the European Medicines Agency has linked semaglutide to a doubled risk of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION) in type 2 diabetes patients. While gastrointestinal issues like nausea and vomiting remain the most frequent complaints, medical experts are highlighting the risk of permanent vision loss in high-risk groups.

Entities

Saxenda · European Medicines Agency · Ozempic · Wegovy · TGA

Claims

What the coverage asserts, and how many sources carry each claim.

Coverage disagrees

Sources make claims that cannot both be true. CLSTR reports the disagreement; it does not decide who is right.

  • "HALMED has received 333 reports of suspected side effects for drugs containing semaglutide, liraglutide, dulaglutide, and tirzepatide since 2014." ordinacija.vecernji.hr

    vs

    "19 percent of the 288 reports received by HALMED were classified as serious." 023.hr · www.poslovni.hr

    The claims provide different total numbers of reports received by HALMED (288 versus 333).

Timeline

  1. about 8 hours ago

    [HEALTH] 6 sources
    Weight loss drugs linked to serious side effects and vision loss

    Global health agencies report rising concerns over side effects from weight loss drugs like semaglutide, including vision impairment (NAION), gastrointestinal issues, and reported deaths in the UK and Australia

  2. 9 days ago

    [HEALTH] 4 sources
    UK regulator reports 216 suspected deaths linked to weight loss injections

    The UK's MHRA has recorded 216 reported deaths and over 158,000 suspected adverse reactions linked to GLP-1 weight loss and diabetes drugs, though officials note these do not prove causality.

Sources

023.hr · index.hr · jutarnji.hr · ordinacija.vecernji.hr · oslobodjenje.ba · poslovni.hr · pozeski.hr · riportal.net.hr · srpskacafe.com · trn.mk